Related Experiment Video
Updated: Mar 8, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
1.2K
Rheumatoid Arthritis: Selecting Monotherapy Versus Combination Therapy
Nimish Mehta1, Lynne Kolton Schneider, Emilie McCardell
1From the *Medscape, LLC New York, NY; and †Freelance Medical Writer, Boca Raton, FL.
Summary
Achieving remission in rheumatoid arthritis (RA) is challenging. This review synthesizes real-world evidence to guide rheumatologists in selecting effective RA monotherapy and combination therapy strategies for better patient outcomes.
Area of Science:
- Rheumatology
- Clinical Pharmacology
Background:
- Rheumatoid arthritis (RA) treatment aims for remission, but many patients remain uncontrolled.
- Current treatment guidelines lack specific strategies for selecting optimal monotherapy and combination regimens.
- Translating clinical trial data to real-world practice for RA management is challenging.
Purpose of the Study:
- To provide practical guidance for selecting rheumatoid arthritis (RA) monotherapy and combination therapy.
- To synthesize evidence from diverse sources, including clinical trials, meta-analyses, patient registries, and pragmatic trials.
- To aid rheumatologists in comparing RA treatment strategies based on real-life effectiveness and safety.
Main Methods:
- Systematic review and synthesis of evidence from meta-analyses of clinical trials.
- Inclusion of data from rheumatoid arthritis (RA) patient registries.
- Analysis of results from pragmatic trial designs to reflect real-world practice.
Main Results:
- Combination therapy is crucial for most rheumatoid arthritis (RA) patients.
- Evidence synthesis aims to bridge the gap between clinical trial findings and real-world patient care.
- Patient case scenarios illustrate practical application of treatment strategies.
Conclusions:
- Effective rheumatoid arthritis (RA) management requires tailored therapeutic strategies.
- Further guidelines are needed for optimal selection of combination therapy in RA.
- This synthesis provides a framework for evidence-based, real-world RA treatment decisions.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
438
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
438
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
675
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
675
01:20Rheumatic Heart Disease IV: Nursing Management
400
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
400
01:23Rheumatic Heart Disease I: Introduction
706
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
706
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
621
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
621
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
848
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
848